Abstract: The aim of this review study was to discuss and highlighting the most important aspects on Rheumatoid arthritis (RA), mainly discussing the diagnosis and therapeutics management, also to review the pathogenesis and causes behind the RA. We conducted detailed search reviewing articles related to Rheumatoid arthritis (RA), using electronic databases; Medline/PubMed, Embase, and Google scholar. Search strategy used following terms through PubMed; “Rheumatoid arthritis” “diagnosis,” “screening,” and “treatment”. We applied restriction to our search, for only these studies published up to May,2017 with English language, and involving human subjects.
RA, a systemic autoimmune disease involving the joints and also various other organs, is associated with death, disability, and also pain. Growing evidence recommends that very early recognition and therapy of RA brings about boosted results and even boosted rates of drug-free remission. The optimal time to treat and recognize RA is unknown; nonetheless, less than 3-- 6 months of symptoms of IA appears to be a good time duration to target for initiation of DMARD therapy, although this target may be difficult to get to as a result of several factors that could affect very early medical diagnosis of RA. The 2010 ACR/EULAR classification requirements show up to recognize RA earlier compared to the 1987 standards, although the performance of these brand-new requirements in leading to improved end results in RA needs further examination.
Keywords: Rheumatoid arthritis (RA), ACR/EULAR classification requirements.
Title: Early Screening for Rheumatoid Arthritis, And Treatment Outcomes, Review
Author: Faisal Rabeea Alanazi, Mohammed Nafy Alruwaily, Mohammed Zhafer Alqarni, Abdullah Sami Bunaian, Nasser Khalid Alotaibi, Abdulaziz Mohammed Alessa, Mansour Abdullah Alnaim
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
